CJC-1295 is a GHRH analog (it tells the pituitary to make GH), while ipamorelin is a growth-hormone secretagogue (it triggers the release of stored GH)
modest improvements in LDL and HDL ratios Liver health: Significant improvements in non-alcoholic fatty liver disease (NAFLD), an increasingly common obesity-related condition Sleep apnea: The SURMOUNT-OSA trial showed tirzepatide reduced sleep apnea severity by up to 63% Joint health: Weight reduction directly reduces mechanical load on hips, knees, and ankles reducing pain and improving mobility Ready to Find Out If GLP-1 Medication Is Right for You
Romero-Gmez M, Lawitz E, Shankar RR, Chaudhri E, Liu J, Lam RLH, et al
Another consideration that many people miss is light exposure
Larsen for expert technical assistance with conducting the animal studies
What Dual-Action Means (GLP-1 + GIP) 4